Blood Glucose Monitoring System Market Size, Share & Industry Analysis, By Device Type (Continuous Glucose Monitoring (CGM) Systems [Sensors and Transmitters & Receivers] and Self-Monitoring Blood Glucose (SMBG) Systems [Blood Glucose Meters, Test Strips, and Lancets]), By Type (Non-invasive and Invasive), By Modality (Wearable and Non-wearable), By Patient Type (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Retail Sales and Institutional Sales), and Regional Forecast, 2025-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 6.3% from 2025 to 2032

Unit

Value (USD Billion)

Segmentation

By Device Type

• Continuous Glucose Monitoring Systems
  • Sensors
  • Transmitters & Receivers
• Self-Monitoring Blood Glucose Systems
  • Blood Glucose Meters
  • Test Strips
  • Lancets

By Modality

• Wearable
• Non-wearable

By Type

• Non-invasive
• Invasive

By Patient Type

• Type-1 Diabetes
• Type-2 Diabetes

By Distribution Channel

• Institutional Sales
• Retail Sales

By Geography

• North America (By Device Type, Type, Modality, Patient Type, Distribution Channel, and Country)
  • U.S. (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
  • Canada (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
• Europe (By Device Type, Type, Modality, Patient Type, Distribution Channel, and Country/Sub-region)
  • U.K. (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
  • Germany (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
  • France (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
  • Italy (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
  • Spain (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
  • Rest of Europe (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
• Asia Pacific (By Device Type, Type, Modality, Patient Type, Distribution Channel, and Country/Sub-region)
  • China (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
  • Japan (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
  • India (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
  • Australia (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
  • Korea (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
  • Rest of Asia Pacific (By Device Type, Type, Modality, Patient Type, and Distribution Channel)
• Rest of the World (By Device Type, Type, Modality, Patient Type, and Distribution Channel)